BioLife Solutions Q2 Revenue Jumps 21% to $28.5M, Adjusted EBITDA Hits $7.4M
BLFS sits 90% above its 52-week low of $17.86.
Summary
BioLife Solutions reported Q2 2026 revenue of $28.5M (+21% YoY) and adjusted EBITDA of $7.4M, demonstrating robust growth in its core biopreservation business ahead of its pending acquisition by Repligen.
Key Events · Earnings and Guidance · BLFS
-
Revenue Up 21% to $28.5M
Q2 2026 total revenue reached $28.5 million, a 21% increase over Q2 2025, driven by the market-leading biopreservation media franchise.
-
Adjusted EBITDA of $7.4M (26% Margin)
Non-GAAP adjusted EBITDA was $7.4 million, or 26% of revenue, up from $5.6 million in Q2 2025, reflecting improved operating leverage.
-
GAAP Net Income Boosted by $42.4M Tax Benefit
GAAP net income was $45.1 million, including a non-cash $42.4 million income tax benefit from the release of a valuation allowance; adjusted net income was $4.2 million.
-
Strong Cash Position of $113.1M
Cash, cash equivalents, and marketable securities totaled $113.1 million as of June 30, 2026, providing ample liquidity ahead of the Repligen acquisition.
Analysis · BLFS · Industrial Applications And Services
BioLife Solutions delivered a strong Q2 with 21% revenue growth and a swing to GAAP profitability, though the $45.1M net income was largely driven by a one-time $42.4M tax benefit. The core business showed solid momentum: adjusted EBITDA of $7.4M (26% margin) and cash of $113M provide ample runway ahead of the Repligen acquisition. The company's biopreservation media dominates with over 70% market share in clinical trials, and 18 approved therapies now use its products. This earnings report reinforces the operational strength that made BioLife an attractive target for Repligen's $1.5B buyout, expected to close in Q4 2026.
At the time of this filing, BLFS was trading at $33.93 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $17.86 to $34.34. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.